An observational study in Spondylodiscitis, sponsored by Assiut University. Status unknown. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2021-02-10.
Sponsored by Assiut University · Observational
To evaluate the long term outcomes of patients with thoracolumbar spondylodiscitis treated surgically by posterior approach.
Outcomes include bony fusion, neurological improvement, pain improvement, implant related complication, recurrence of infection and or reoperation rate
spondylodiscitis is characterized by infection that primarily affects the intervertebral disc and adjacent vertebrae. The estimated incidence of spondylodiscitis, ranging from 0.2 to 10 per 100,000 inhabitants per year, has increased in recent years, which is likely associated with an aging population, higher prevalence of chronic disease, and more effective diagnostic techniques. Spondylodiscitis is a life-threatening disease with a mortality rate of 2-20% that is often associated with potential complications, such as paraspinal abscess, epidural abscess, meningitis, spinal instability, and neurologic deficiency. The relapse rates were reported to be as high as 32% in the literature. The aims of this study are to evaluate improvements, complications, recurrence and reoperation rates in Assiut university hospitals.
24 studies on the registry are indexed under Discitis; 5 are open to participants now.
This study's planned enrollment of 40 is below the median of 104 across 16 observational studies indexed under Discitis.
Browse Discitis studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
All Patients suffered from thoracolumbar spondylodiscitis and treated surgically by posterior approach in Assiut university hospitals from January 2016 to December 2017
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
All patients had thoracolumbar spondylodiscitis from number 1 thoracic vertebra till number 1 sacral vertebra.
Exclusion Criteria:
Patients with incomplete follow up.
Bony fusion success
the degree of bridging bone across the fused vertebral bodies by using x-ray, CT scan and MRI if needed
Time frame: 2 years
modified Oswestry disability index
for patient quality of life postoperative
Time frame: 2 years
visual analogue scale
the amount of pain sensed by the patient pre and post-operative
Time frame: 2years
American spinal injury Association (ASIA) Impairment score
to asses neurological outcomes pre operative and at 2 years follow up.
Time frame: 2 years
No study locations are listed for this record.
Start is estimated for Jan 2021; primary completion for Jun 2021, 4 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.